跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,749 条关于
“IMM2510/AXN-2510”
全部
19,749
临床试验
18,494
药物
793
机构
23
资讯
439
去年
Instil Bio's PD-L1xVEGF Bispecific Antibody Shows Promise in NSCLC, Driving 48% Stock Surge
去年
Instil Bio and ImmuneOnco Advance PD-(L)1xVEGF Bispecific Antibody Clinical Development Strategy
去年
Instil Bio's Partner ImmuneOnco Doses First Patient in NSCLC Trial with IMM2510/SYN-2510
8个月前
Instil Bio Terminates Licensing Agreement and Discontinues Lead Cancer Drug Development
去年
Instil Bio Appoints Veteran Oncologist Jamie Freedman as Chief Medical Officer to Advance PD-L1xVEGF Bispecific
去年
DLL3-Targeted CAR-T Therapy LB2102 Shows Promise in Relapsed/Refractory Small Cell Lung Cancer
去年
AnX Robotica Receives FDA 510(k) Clearance for MotiliCap and MotiliScan GI Motility Monitoring System
去年
InventisBio's D-2570 Shows Promise in Phase 2 Psoriasis Trial
去年
ATN-022 Shows Promising Activity in Advanced Gastric Cancer
9个月前
Biohaven's BHV-1510 Shows Promising Early Cancer Data in Combination Trial
第 1 页,共 44 页
上一页
下一页